NCT04239209 is a NA clinical trial of Indirect - other patients in Critical Illness, sponsored by Johns Hopkins University.

Who is sponsoring NCT04239209?

NCT04239209 is sponsored by Johns Hopkins University.

What drugs are being tested in NCT04239209?

Interventions in NCT04239209: Indirect - other patients, Indirect - physiology, Redirection, Direct communication.

What condition does NCT04239209 study?

NCT04239209 studies Critical Illness.

Is NCT04239209 still recruiting?

NCT04239209 is currently completed. Last updated 27 January 2020.

Last reviewed 2020-01-27 · How we verify

NCT04239209

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Intensivist Communication on Surrogate Prognosis Interpretation

Completed NA Last updated 27 January 2020

What this trial tests

NA trial testing Indirect - other patients in Critical Illness in 302 participants. Completed in 17 October 2019.

Timeline

27 September 2019

Primary endpoint
17 October 2019

17 October 2019

Quick facts

Lead sponsor	Johns Hopkins University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	302
Start date	27 September 2019
Primary completion	17 October 2019
Estimated completion	17 October 2019
Sites	1 location across United States

Drugs / interventions tested

Indirect - other patients
Indirect - physiology
Redirection
Direct communication

Conditions studied

Critical Illness — all drugs for Critical Illness →

Sponsor

Johns Hopkins University

Who can join

18 and older, any sex, with Critical Illness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the effect of physician communication styles on the interpretation of prognosis by family members of chronically-ill patients. Participants were randomized to view one of four videos how depicting different physicians disclose prognosis when physicians expect an ICU patient to die.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effect of Intensivist Communication in a Simulated Setting on Interpretation of Prognosis Among Family Members of Patients at High Risk of Intensive Care Unit Admission: A Randomized Trial.
Oppenheim IM, Lee EM, Vasher ST, Zaeh SE, et al · · 2020 · cited 12× · PMID 32236533 · DOI 10.1001/jamanetworkopen.2020.1945

Verify or expand the search:

Other recruiting trials for Critical Illness

Currently open trials in the same condition.

NCT06189924 — Exhaled Breath Condensate Analysis in Mechanically Ventilated Patients · recruiting
NCT07418242 — Prognostic Value of Novel Biomarkers on Adverse Renal Outcomes in High-Risk Cardiac Surgery Patients · recruiting
NCT07101640 — PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary Dysp · Phase 1, PHASE2 · recruiting
NCT07177183 — Low Serum Creatinine as a Predictor of Prolonged Mechanical Ventilation and Weaning Failure · NA · recruiting
NCT07369258 — Clinical Application of Listening to Music to Prevent Delirium in the Intensive Care Unit · NA · recruiting

Other Johns Hopkins University trials

Trials by the same sponsor.

NCT06236542 — Tracheostomy Robotics and Cutting-edge Health Education for Airway Safety · NA · not yet recruiting
NCT07532252 — Daridorexant for Alcohol Use Disorder · Phase 2 · not yet recruiting
NCT06687655 — Impact of Exogenous Ketones on Sleep Apnea · Phase 1, PHASE2 · not yet recruiting
NCT07079111 — 3D Printed Occlusal Splints for Intraoperative Use · NA · not yet recruiting
NCT02998502 — The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04239209 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Johns Hopkins University
Last refreshed: 27 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04239209.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing